Core Viewpoint - The company is planning to issue shares to acquire 100% equity of Weigao Purui Pharmaceutical Packaging Co., Ltd, which will become a wholly-owned subsidiary after the transaction is completed [1][2]. Group 1: Transaction Details - The transaction is currently in the planning stage, and no formal agreement has been signed yet [2]. - The company has applied for a stock suspension starting from October 20, 2025, to prevent significant impacts on its stock price [1][2]. - The transaction requires approval from the company's board, shareholders, and relevant regulatory authorities before it can be officially implemented [2]. Group 2: Investor Communication - The company emphasizes the importance of maintaining investor interests and will adhere to legal and regulatory requirements during the transaction process [2]. - The company will disclose information regarding the transaction's progress and will apply for stock resumption once the relevant matters are confirmed [2].
山东威高血液净化制品股份有限公司关于筹划发行股份购买资产暨关联交易事项停牌的进展公告